The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 99:174-180, September 1942
doi: 10.1176/appi.ajp.99.2.174
© 1942 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by LENNOX, W. G.
* Search for Related Content
PubMed
* Articles by LENNOX, W. G.

BRAIN INJURY, DRUGS, AND ENVIRONMENT AS CAUSES OF MENTAL DECAY IN EPILEPSY

WILLIAM G. LENNOX M. D.1

1 The Department of Neurology, Harvard Medical School, and the Neurology Unit, Boston City Hospital, Boston, Mass.

This is the second of a series of three papers dealing with mental deterioration in epilepsy. Comparison was made of the mental state of 449 "symptomatic" and 1456 "essential" epileptics. Twenty-six per cent of the symptomatic and 10 per cent of the essential group showed definite deterioration, although the former group had experienced fewer seizures. The elimination of patients who were mentally deficient at birth decreased the disparity to 12 and 6 per cent respectively. With respect to the age of patients at the onset of seizures, serious deterioration was more manifest in the symptomatic group in all ages, but the difference was greatest if seizures began in adult life. With respect to the duration of epilepsy, again deterioration was more marked in the symptomatic group in all periods, but the difference was greatest if the epilepsy had just begun. In the symptomatic group deterioration was more often present before seizures began.

Patients whose mentality improved while using anticonvulsant drugs numbered for phenobarbital 30 per cent, for bromides 26 per cent, and for patent medicines 13 per cent. Improvement of seizures was noted, respectively, in 65, 53 and 40 per cent of patients reporting the use of these drugs.

The psychological causes of pseudodeterioration are important but could not be evaluated in this study.




This article has been cited by other articles:


Home page
NeurologyHome page
K. J. Meador
Cognitive outcomes and predictive factors in epilepsy
Neurology, April 23, 2002; 58(90085): S21 - 26.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
B. F.D. Bourgeois
Differential Cognitive Effects of Antiepileptic Drugs
J Child Neurol, February 1, 2002; 17(2_suppl): 2S28 - 2S33.
[Abstract] [PDF]


Home page
J Child NeurolHome page
W. T. Seidel and W. G. Mitchell
Cognitive and Behavioral Effects of Carbamazepine in Children: Data From Benign Rolandic Epilepsy
J Child Neurol, November 1, 1999; 14(11): 716 - 723.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M. Matsuura
Epileptic psychoses and anticonvulsant drug treatment
J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 231 - 233.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
E. M. Bebin and M. R. Gomez
Prognosis in Sturge-Weber Disease: Comparison of Unihemispheric and Bihemispheric Involvement
J Child Neurol, July 1, 1988; 3(3): 181 - 184.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1942 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org